SAM
CRL icon

Smartleaf Asset Management’s Charles River Laboratories CRL Stock Holding History

Smartleaf Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Buy
1,041
+297
+40% +$55.1K 0.01% 859
2025
Q4 		$150K Buy
744
+94
+14% +$17.1K 0.01% 961
2025
Q3 		$95.5K Buy
650
+294
+83% +$46.7K 0.01% 1096
2025
Q2 		$53.4K Sell
356
-3
-0.8% -$400 ﹤0.01% 1139
2025
Q1 		$55.8K Sell
359
-100
-22% -$16.8K 0.01% 1089
2024
Q4 		$84.2K Buy
459
+175
+62% +$33.7K 0.01% 921
2024
Q3 		$56.3K Buy
284
+81
+40% +$16.8K 0.01% 877
2024
Q2 		$42.1K Buy
203
+29
+17% +$6.57K 0.01% 788
2024
Q1 		$46.9K Buy
174
+34
+24% +$8.12K 0.01% 689
2023
Q4 		$33.4K Buy
+140
New +$27.5K 0.01% 593

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Smartleaf Asset Management's CRL Position: Q1 2026 in Review

Smartleaf Asset Management increased its Charles River Laboratories (CRL) stake by 40% in Q1 2026, buying an estimated $55.1K and bringing the position to 1,041 shares worth $166K. The position accounts for 0.01% of the portfolio, ranked #859.

Smartleaf Asset Management first reported a position in CRL in Q4 2023 and has held it in 10 quarters since. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Smartleaf Asset Management held 1,041 shares of Charles River Laboratories worth $166K as of Q1 2026.
  • Smartleaf Asset Management bought 297 Charles River Laboratories shares in Q1 2026, an estimated $55.1K.
  • Charles River Laboratories made up 0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #859 holding.
  • Smartleaf Asset Management first reported a position in Charles River Laboratories in Q4 2023 and has held it in 10 quarters since.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.